Free Trial
→ Elon Musk’s $1 Quadrillion AI IPO (From Brownstone Research) (Ad)tc pixel Free BLACR Stock Alerts

This company has been marked as potentially delisted and may not be actively trading.

Bellevue Life Sciences Acquisition (BLACR) Competitors

Compare

BLACR vs. ABLLL, ASGI, AFJKR, ATMCR, and ATLCL

Should you be buying Bellevue Life Sciences Acquisition stock or one of its competitors? The main competitors of Bellevue Life Sciences Acquisition include Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 (ABLLL), Abrdn Global Infrastructure Income Fund (ASGI), Aimei Health Technology (AFJKR), AlphaTime Acquisition (ATMCR), and Atlanticus Holdings Co. 6.125% Senior Notes due 2026 (ATLCL). These companies are all part of the "-" industry.

How does Bellevue Life Sciences Acquisition compare to Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028?

Bellevue Life Sciences Acquisition (NASDAQ:BLACR) and Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 (NASDAQ:ABLLL) are both - industry companies, but which is the superior business? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, risk, dividends, profitability, analyst recommendations, earnings and valuation.

Company Net Margins Return on Equity Return on Assets
Bellevue Life Sciences AcquisitionN/A N/A N/A
Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 N/A N/A N/A

In the previous week, Bellevue Life Sciences Acquisition's average media sentiment score of 0.00 equaled Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028'saverage media sentiment score.

Company Overall Sentiment
Bellevue Life Sciences Acquisition Neutral
Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bellevue Life Sciences AcquisitionN/AN/AN/AN/AN/A
Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028$235.24MN/AN/AN/AN/A

Summary

Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 beats Bellevue Life Sciences Acquisition on 1 of the 1 factors compared between the two stocks.

How does Bellevue Life Sciences Acquisition compare to Abrdn Global Infrastructure Income Fund?

Abrdn Global Infrastructure Income Fund (NYSE:ASGI) and Bellevue Life Sciences Acquisition (NASDAQ:BLACR) are both - industry companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abrdn Global Infrastructure Income Fund$85.30MN/AN/AN/AN/A
Bellevue Life Sciences AcquisitionN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Abrdn Global Infrastructure Income FundN/A N/A N/A
Bellevue Life Sciences Acquisition N/A N/A N/A

In the previous week, Abrdn Global Infrastructure Income Fund had 1 more articles in the media than Bellevue Life Sciences Acquisition. MarketBeat recorded 1 mentions for Abrdn Global Infrastructure Income Fund and 0 mentions for Bellevue Life Sciences Acquisition. Bellevue Life Sciences Acquisition's average media sentiment score of 0.00 beat Abrdn Global Infrastructure Income Fund's score of -2.00 indicating that Bellevue Life Sciences Acquisition is being referred to more favorably in the news media.

Company Overall Sentiment
Abrdn Global Infrastructure Income Fund Very Negative
Bellevue Life Sciences Acquisition Neutral

Summary

Abrdn Global Infrastructure Income Fund beats Bellevue Life Sciences Acquisition on 2 of the 3 factors compared between the two stocks.

How does Bellevue Life Sciences Acquisition compare to Aimei Health Technology?

Aimei Health Technology (NASDAQ:AFJKR) and Bellevue Life Sciences Acquisition (NASDAQ:BLACR) are both - industry companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aimei Health TechnologyN/AN/AN/AN/AN/A
Bellevue Life Sciences AcquisitionN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Aimei Health TechnologyN/A N/A N/A
Bellevue Life Sciences Acquisition N/A N/A N/A

In the previous week, Aimei Health Technology's average media sentiment score of 0.00 equaled Bellevue Life Sciences Acquisition'saverage media sentiment score.

Company Overall Sentiment
Aimei Health Technology Neutral
Bellevue Life Sciences Acquisition Neutral

Summary

Aimei Health Technology and Bellevue Life Sciences Acquisition tied by winning 0 of the 0 factors compared between the two stocks.

How does Bellevue Life Sciences Acquisition compare to AlphaTime Acquisition?

AlphaTime Acquisition (NASDAQ:ATMCR) and Bellevue Life Sciences Acquisition (NASDAQ:BLACR) are both - industry companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AlphaTime AcquisitionN/AN/AN/AN/AN/A
Bellevue Life Sciences AcquisitionN/AN/AN/AN/AN/A

In the previous week, AlphaTime Acquisition's average media sentiment score of 0.00 equaled Bellevue Life Sciences Acquisition'saverage media sentiment score.

Company Overall Sentiment
AlphaTime Acquisition Neutral
Bellevue Life Sciences Acquisition Neutral

Company Net Margins Return on Equity Return on Assets
AlphaTime AcquisitionN/A N/A N/A
Bellevue Life Sciences Acquisition N/A N/A N/A

Summary

AlphaTime Acquisition and Bellevue Life Sciences Acquisition tied by winning 0 of the 0 factors compared between the two stocks.

How does Bellevue Life Sciences Acquisition compare to Atlanticus Holdings Co. 6.125% Senior Notes due 2026?

Bellevue Life Sciences Acquisition (NASDAQ:BLACR) and Atlanticus Holdings Co. 6.125% Senior Notes due 2026 (NASDAQ:ATLCL) are both - industry companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, media sentiment, earnings, analyst recommendations, institutional ownership, profitability and risk.

In the previous week, Bellevue Life Sciences Acquisition's average media sentiment score of 0.00 equaled Atlanticus Holdings Co. 6.125% Senior Notes due 2026'saverage media sentiment score.

Company Overall Sentiment
Bellevue Life Sciences Acquisition Neutral
Atlanticus Holdings Co. 6.125% Senior Notes due 2026 Neutral

Company Net Margins Return on Equity Return on Assets
Bellevue Life Sciences AcquisitionN/A N/A N/A
Atlanticus Holdings Co. 6.125% Senior Notes due 2026 N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bellevue Life Sciences AcquisitionN/AN/AN/AN/AN/A
Atlanticus Holdings Co. 6.125% Senior Notes due 2026N/AN/AN/AN/AN/A

Summary

Bellevue Life Sciences Acquisition and Atlanticus Holdings Co. 6.125% Senior Notes due 2026 tied by winning 0 of the 0 factors compared between the two stocks.

Get Bellevue Life Sciences Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for BLACR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BLACR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BLACR vs. The Competition

Export
MetricBellevue Life Sciences Acquisition- Industry SectorNASDAQ Exchange
Market CapN/A$1.43M$2.80B$11.77B
Dividend YieldN/A8.95%15.26%5.26%
P/E RatioN/AN/A14.4827.07
Price / SalesN/AN/A2,089.8273.43
Price / CashN/AN/A51.5253.90
Price / BookN/AN/A4.846.69
Net IncomeN/AN/A-$234.32M$332.64M

Bellevue Life Sciences Acquisition Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BLACR
Bellevue Life Sciences Acquisition
N/A$0.23
flat		N/AN/A$0.00N/AN/A2
ABLLL
Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028
N/A$25.98
+0.2%		N/AN/A$0.00$235.24MN/AN/A
ASGI
Abrdn Global Infrastructure Income Fund
N/A$23.78
-0.6%		N/AN/A$0.00$85.30MN/AN/A
AFJKR
Aimei Health Technology
N/A$0.29
+7.5%		N/AN/A$0.00N/AN/AN/A
ATMCR
AlphaTime Acquisition
N/A$0.19
flat		N/AN/A$0.00N/AN/A2

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:BLACR) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel